1. P469 The PROPER study: interim analysis of a pan-European real-world study of SB5 adalimumab biosimilar after transition from reference adalimumab in patients with Crohn's disease. (27th May 2021) Authors: Dignass, A; Gisbert, J; Freudensprung, U; Addison, J Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S459 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P585 IBD Reference and Biosimilar adalimumab CroSS over Study (iBaSS): a mixed methods clinical trial of patients transitioning between originator and biosimilar adalimumab. Qualitative findings from an interim analysis presenting the patient perspective. (27th May 2021) Authors: Young, D; Latter, S; Harvey, J; Addison, J; Freudensprung, U; Cummings, F Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S537 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗